Regarding Gal9, non-significant trends toward elevated levels in patients with increased DA were found in SLE (p = 0.0306), PS (p = 0.0094), and RA (p = 0.0240) (Supplementary Figure S2). This evidence concerns the gene LGALS9 and rheumatoid arthritis.